Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | ASPH | Q12797 | 3/20 | 0.59 |
| ▸ | KDM8 | Q8N371 | 3/20 | 0.59 |
| ▸ | KDM5A | P29375 | 2/20 | 0.59 |
| ▸ | KDM3A | Q9Y4C1 | 2/20 | 0.59 |
| ▸ | KDM6B | O15054 | 1/20 | 0.59 |
| ▸ | TET3 | O43151 | 1/20 | 0.59 |
| ▸ | KDM4A | O75164 | 1/20 | 0.59 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | KDM5C | P41229 | 1/20 | 0.59 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.59 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.59 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.59 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.59 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.59 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.59 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.59 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231979 | 0.98 | KDM4E (0.61) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL29954072 | 0.98 | KDM4E (0.61) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL3223370 | 0.80 | KMO (0.65) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL1612977 | 0.79 | ALDH1A1 (0.50) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL7692385 | 0.79 | ADORA3 (0.45) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL23874595 | 0.79 | GRM5 (0.43) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL30668214 | 0.79 | ADORA3 (0.45) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL30004144 | 0.79 | ALDH1A1 (0.50) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL24572141 | 0.79 | KMO (0.62) | KDM4EALDH1A1ASPHKDM8KDM5A | |
| SCHEMBL30800092 | 0.78 | KMO (0.71) | KDM4EALDH1A1ASPHKDM8KDM5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8003688-B2 | Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract | IMMUPHARM APS (DK) | 2011-08-23 | — | — | US | disclosed |
| US-7671086-B2 | Pharmaceutical compositions comprising flavonoids and menthol | IMMUPHARM A/S (DK) | 2010-03-02 | — | — | US | disclosed |
| US-20090227670-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING FLAVONOIDS AND MENTHOL | IMMUPHARM A/S (DK) | 2009-09-10 | — | — | US | disclosed |
| US-7585890-B2 | Pharmaceutical compositions comprising flavonoids and menthol | IMMUNPHARM A/S (DK) | 2009-09-08 | — | — | US | disclosed |
| EP-2089422-A1 | METHODS OF SEPARATING NUCLEIC ACIDS AND PROTEIN | Natimmune A/S (DK) | 2009-08-19 | — | — | EP | disclosed |
| WO-2008106979-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING FLAVONOIDS AND XYLITOL | IMMUPHARM A/S (DK) | 2008-09-12 | — | — | WO | disclosed |
| CN-100411617-C | Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract | IMMUPHARM APS (DK) | 2008-08-20 | — | — | CN | disclosed |
| WO-2008064686-A1 | METHODS OF SEPARATING NUCLEIC ACIDS AND PROTEIN | NATIMMUNE A/S (DK) | 2008-06-05 | — | — | WO | disclosed |
| EP-1556021-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING FLAVONOIDS AND MENTHOL | IMMUPHARM AS (DK) | 2007-12-19 | — | — | EP | disclosed |
| US-7166640-B2 | Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract | IMMUPHARM APS (DK) | 2007-01-23 | — | — | US | disclosed |
| US-20060148726-A1 | Pharmaceutical compositions comprising flavonoids and menthol | IMMUPHARM A/S C/O NOVI A/S, NIELS JERNES VEJ 10 (DK) | 2006-07-06 | — | — | US | disclosed |
| EP-1307189-B1 | USE OF HYDROXYETHYLRUTOSIDES FOR TREATING SYMPTOMS OF COMMON COLD, ALLERGIC RHINITIS AND INFECTIONS RELATING TO THE RESPIRATORY TRACT | IMMUPHARM APS (DK) | 2006-05-10 | — | — | EP | disclosed |
| CN-1717227-A | Pharmaceutical compositions comprising flavonoids and menthol | IMMUPHARM AS (DK) | 2006-01-04 | — | — | CN | disclosed |
| US-20050245467-A1 | Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract | IMMUPHARM APS (DK) | 2005-11-03 | — | — | US | disclosed |
| EP-1556021-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING FLAVONOIDS AND MENTHOL | Immupharm A/S (DK) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004037237-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING FLAVONOIDS AND MENTHOL | IMMUPHARM A/S (DK) | 2004-05-06 | — | — | WO | disclosed |
| US-20040053858-A1 | Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract | IMMUPHARM APS (DK) | 2004-03-18 | — | — | US | disclosed |
| CN-1466454-A | Method for treating symptoms of common cold, allergic rhinitis and respiratory tract related infections | ���·�ķ��˾ | 2004-01-07 | — | — | CN | disclosed |
| EP-1307189-A2 | METHOD OF TREATING SYMPTOMS OF COMMON COLD, ALLERGIC RHINITIS AND INFECTIONS RELATING TO THE RESPIRATORY TRACT | Immupharm APS (DK) | 2003-05-07 | — | — | EP | disclosed |
| WO-2002009699-A2 | METHOD OF TREATING SYMPTOMS OF COMMON COLD, ALLERGIC RHINITIS AND INFECTIONS RELATING TO THE RESPIRATORY TRACT | IMMUPHARM APS (DK) | 2002-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148726-A1 | Pharmaceutical compositions comprising flavonoids and menthol | CHIA, MAVS, C1QBP | KDM4E 430/4885ALDH1A1 1674/4885ASPH 2488/4885 |
| US-20050245467-A1 | Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract | CMA1, CHIA, C1QBP | KDM4E 4189/4885ALDH1A1 1900/4885ASPH 776/4885 |
| US-20040053858-A1 | Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract | CMA1, CHIA, C1QBP | KDM4E 4189/4885ALDH1A1 1900/4885ASPH 776/4885 |
| US-20090227670-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING FLAVONOIDS AND MENTHOL | CHIA, MAVS, C1QBP | KDM4E 430/4885ALDH1A1 1674/4885ASPH 2488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.